NOVA Medical School
CEDOC
Cláudia Guimas de Almeida, Ph.D. in Neurosciences (2007) in the Gunnar Gouras lab (Weill Medical College of Cornell University; USA). Cláudia was an EMBO and a Marie Curie Post-doc fellow in Cell biology (2007-2012) at the Institut Curie (France) in Daniel Louvard lab. Cláudia has been a principal investigator of the Neuronal Trafficking in Aging lab at CEDOC, the Chronic Research Center at NOVA Medical School (NMS) in Lisbon since 2013, supported by the Portuguese Science Foundation (FCT). At CEDOC-NMS, Cláudia is co-coordinator of the Biomedical Research master program (NBR), the scientific Coordinator Microscopy facility; a member of NMS Scientific Council. Cláudia has 19 publications (>4000 citations) on intracellular trafficking mechanisms in healthy and Alzheimer's disease cells. Her group has discovered the cellular mechanisms whereby two top genetic risk factors, Bin1 and CD2AP, may contribute to amyloid endocytic production in late-onset Alzheimer's disease (EMBO reports, JBC), and whereby normal aging potentiates amyloid production, which may to aging-dependent synaptic decline (Journal of Cell Science). Her group is investigating the mechanisms of synaptic decline in aging and late-onset Alzheimer's disease to identify novel therapeutic targets to delay or treat Alzheimer's disease.

Presenter of 1 Presentation

ENDOSOMAL TRAFFICKING DEFECTS IN AGING AND ALZHEIMER’S DISEASE INCREASE INTRACELLULAR BETA-AMYLOID

Session Type
SYMPOSIUM
Date
Thu, 17.03.2022
Session Time
09:10 AM - 10:55 AM
Room
ONSITE: 131-132
Lecture Time
10:10 AM - 10:25 AM

Abstract

Aims

The etiology of late-onset Alzheimer’s disease (LOAD) is multifactorial, with aging being the most significant risk factor and genetic predisposition accelerating the disease onset. While dominant mutations in the rare early-onset familial AD lead to excessive neuronal production of the longest form of beta-amyloid (Abeta42), in LOAD, it remains to be established if Ab42 production increases. Abeta is produced intracellularly upon APP processing in endosomes and controlled by the trafficking of APP and its secretases. We hypothesize that endosomal trafficking dysfunction is a causal mechanism of Abeta accumulation in LOAD.

We aim to dissect the mechanisms whereby LOAD risk factors and neuronal aging alter endocytic trafficking to potentiate Abeta42 production.

Methods

We analyzed wild-type primary mouse cortical neurons matured or aged in culture using a sensitive cell biological and neurobiological approach to determine APP and BACE1 trafficking alterations and their impact on the Abeta42 production.

Results

We have discovered that AD patients’ mutations in Bin1 and CD2AP (LOAD genetic risk factors) increase Abeta42 endocytic production, recapitulating the impact of Bin1 and CD2AP loss of function on BACE1 recycling and APP sorting to lysosomal degradation, indicating that the mutations may be pathological. Importantly, we discovered that neuronal aging alone potentiates clathrin and actin-mediated APP endocytosis, increasing intracellular Abeta42.

Conclusions

Our results highlight the importance of endocytic trafficking defects, driven by LOAD genetic risk factors and aging, as a central LOAD mechanism.

Hide